Effect of 13-cis-retinoic acid and α-interferon on transforming growth factor in patients with rising prostate-specific antigen

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Clinical Cancer Research

• Publication date

  1997-11-01

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy.

  1995cited by this paper
• Transforming Growth Factor β2 (TGF-β2) Levels in Plasma of Patients with Metastatic Breast Cancer Treated with Tamoxifen

  1995cited by this paper
• Myasthenia gravis during interferon alfa therapy

  1995cited by this paper
• Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.

  1995cited by this paper
• Elevated Plasma Transforming Growth Factor-β1 Levels in Breast Cancer Patients Decrease After Surgical Removal of the Tumor

  1995cited by this paper
• Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer

  1995cited by this paper
• Combination adriamycin and suramin induces apoptosis in bcl-2 expressing prostate carcinoma cells.

  1995cited by this paper
• Prostate-specific antigen decline: a major prognostic factor for prostate cancer treated with radiation therapy.

  1994cited by this paper
• Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide.

  1993cited by this paper
• Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cells.

  1993cited by this paper
• Prostate‐specific antigen. An important marker for prostate cancer treated by external beam radiation therapy

  1993cited by this paper
• 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.

  1992cited by this paper
• 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.

  1992cited by this paper
• Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer.

  1992cited by this paper
• Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

  1992cited by this paper
• Effects of Interferon βser and Transforming Growth Factor β on Prostatic Cell Lines

  1991cited by this paper
• Prostate specific antigen and local recurrence after radical prostatectomy.

  1990cited by this paper
• Clinical use of prostate specific antigen in patients with prostate cancer.

  1989cited by this paper
• Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction.

  1980cited by this paper

• Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501)

  2014cites this paper
• A phase I trial of weekly paclitaxel, 13-cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies

  2003cites this paper
• Retinol metabolism and lecithin:retinol acyltransferase levels are reduced in cultured human prostate cancer cells and tissue specimens.

  2002cites this paper
• Vitamin A and apoptosis in prostate cancer.

  2002cites this paper
• Antiprogression Agents for Prostate Cancer

  2001cites this paper
• Targeting apoptosis in prostate cancer.

  2001cites this paper
• Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer.

  2000cites this paper
• Differential Modulation of Transforming Growth Factor-β by Betamethasone-17- Valerate and Isotretinoin: Corticosteroid Decreases and Isotretinoin Increases the Level of Transforming Growth Factor-β in Suction Blister Fluid

  2000cites this paper
• Basement membrane zone proteins, epithelial integrins and TGF-β system in reepithelialization, dermatitis herpetiformis and psoriasis : modulation by isotretinoin, betamethasone and calcipotriol

  2000cites this paper
• Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy.

  2000cites this paper
• Clinical trials of immunotherapy for advanced prostate cancer.

  2000cites this paper
• Differentiation Therapy For Prostate Cancer

  2000cites this paper
• Prospects of immunotherapy for the treatment of prostate carcinoma--a review.

  1999cites this paper
• Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignancies.

  1999cites this paper